Moreover, in the colon of patients with CRC with more advanced stages, classified as III and IV stage, the expression of ADGRF5 was higher than in patients with CRC stages corresponding to I and II stage (p < 0.05). Here, ADGRF5 is linked to colorectal carcinoma.